Healthcare with Confidence
Acute Lymphoblastic Leukemia (ALL) Treatment in Israel – Updated Approaches
Acute Lymphoblastic Leukemia (ALL) is a fast-growing type of blood cancer that starts in the bone marrow and leads to the overproduction of immature white blood cells called lymphoblasts. ALL commonly affects children but also occurs in adults, especially those over the age of 65.
Israel is recognized as one of the top countries in the world for treating ALL, offering a combination of advanced diagnostics, personalized treatment plans, clinical research access, and innovative therapies — including CAR-T cell therapy, immunotherapy, and targeted drugs.
If you or your loved one has been diagnosed with leukemia, you can request an online consultation with a top Israeli hematologist-oncologist.
⇒ Leading Hematologists – Consultation Online
Israel is a global leader in blood cancer treatment, especially childhood leukemia.
Why Choose Israel for ALL Treatment?
- World-renowned hematologists and oncologists
- Evidence-based and internationally approved leukemia treatment protocols
- Access to innovative therapies like CAR-T treatment in Israel
- Comprehensive care — from diagnosis to recovery and follow-up
- Tailored treatment for both children and adults
- Accredited cancer centers
How ALL Is Diagnosed in Israel
Israeli clinics use an advanced combination of laboratory, imaging, and genetic tools to make an accurate diagnosis, including:
- Complete blood count and peripheral smear
- Bone marrow biopsy & aspiration
- Immunophenotyping (flow cytometry)
- Cytogenetic and molecular oncology testing
- PET-CT, MRI, or ultrasound as needed
These tests help determine the exact leukemia subtype, predict treatment response, and create a customized therapy plan.
ALL Treatment Options in Israel
- Chemotherapy
The first-line treatment for most patients. Pediatric protocols used in Israel offer high remission rates with reduced toxicity. - Targeted Therapy
Based on genetic mutations (e.g., Philadelphia chromosome-positive ALL), including kinase inhibitors and monoclonal antibodies. - Immunotherapy (including CAR-T cells)
CAR-T cell therapy in Israel has shown full remission in more than 70% of patients with relapsed or refractory ALL. It is considered the most advanced form of leukemia treatment available today. - Bone Marrow Transplant (BMT)
Recommended for high-risk patients or after relapse. Both autologous and allogeneic transplants are available in Israeli centers.
CAR-T Cell Therapy – Breakthrough for Relapsed ALL
CAR-T therapy is now available in Israel (since 2025) and continues to expand in 2026. It is especially effective for patients who:
- Did not respond to chemotherapy
- Relapsed after bone marrow transplant
- Have aggressive or difficult-to-treat ALL
CAR-T programs are available in Israeli leading hospitals with dedicated units for both adults and children.
ALL Treatment for Children vs Adults
- Children: Survival rates reach 85–90% with modern treatment protocols in Israel.
- Adults: Treatment is more challenging, but new immunotherapies and precision medicine approaches are showing promising outcomes.
Israeli protocols are updated annually based on the latest clinical research and international recommendations.
How to Start ALL Treatment in Israel
We assist international patients with:
- Online consultations with Israeli leukemia specialists
- Review of medical records and treatment recommendations
- Arranging diagnosis and treatment planning
- Scheduling treatment at top Israeli hospitals
- Full support with logistics and translation services
Contact us via website, WhatsApp, or email — we’ll reply within nearest hours.
